Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma (Q77378845)
Jump to navigation
Jump to search
scientific article published on 01 December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma |
scientific article published on 01 December 2001 |
Statements
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma (English)
F Zallio
S Vallet
I Ricca
A Cuttica
D Caracciolo
P Corradini
M Astolfi
S Sametti
F Volpato
P Bondesan
M Boccadoro
A Pileri
A M Gianni